«Биткоиномания»: прогнозы и возможности
Stentys SA is engaged in the design, development and marketing of self-expanding stents used in treating cardiovascular diseases. It provides innovative solutions to the interventional cardiologist to treat patients with acute myocardial infarction and other complex coronary disease. The company's products include xpositions, mistent, stentys btk, stentys ac, ses stent and stentys stent. Stentys was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Paris, France.